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Preeclampsia is an important cause of maternal and prenatal morbidity and mor-
tality in the developing countries. Changes in thyroid function/antibodies profiles in
preeclamptic women are controversial and were never investigated before in Sudan. A
case–control study was conducted at Medani Hospital, Sudan, to investigate thyroid
function/antibodies in preeclampsia. The sociodemographic, medical history was gath-
ered using questionnaires. Thyroid hormones [thyroid-stimulating hormone (TSH), free tri-
iodothyronine (T3), and free thyroxine (T4)] and anti-thyroid peroxidase (anti-TPO) and anti-
thyroglobulin (anti-TG) antibodies were measured using ELISA. The three groups [con-
trols, mild, and severe preeclampsia (SP) (55 women in each arm)] were matched in age
and parity. While median (interquartile range) of TSH was significantly lower, both free T3
and free T4 levels were significantly higher in women with preeclampsia than in the healthy
controls. There was no significant difference in the TSH levels in women with MP and SP.
In comparison with women with MP, women with SP had significantly higher levels of free
T3 and significantly lower levels of free T4. While anti-TPO antibodies were significantly
higher, anti-TG antibodies were significantly lower in women with preeclampsia. Likewise,
anti-TPO antibodies were significantly higher and anti-TG antibodies were significantly
lower in women with SP than in women with MP. In linear regression, preeclampsia
was significantly associated with TSH ( 0.675 IU/ml, P=0.009), free T3 (0.977pg/ml,
P<0.001), and free T4 (0.186 ng/dl, P<0.001) levels. In contrast to anti-TG antibodies
and TSH, Sudanese patients with preeclampsia had higher levels of T3 and T4 hormones
and anti-TPO antibodies irrespective of parity, gestational age, and hemoglobin levels.
Keywords: preeclampsia, thyroid-stimulating hormone, thyroxine, tri-iodothyronine, thyroid antibodies, Sudan,
thyroid
Introduction
Preeclampsia is a multi-organ syndrome of pregnancy, characterized by the new onset of hyper-
tension and proteinuria after 20weeks of gestation (1). It is a big health problem where it is the
main cause of maternal and perinatal morbidity and mortality worldwide (2). The exact underlying
patho-physiology of preeclampsia is not yet fully understood; however, placental pathology leading
to preeclampsia is suggested, with inadequate/inappropriate cytotrophoblast invasion, maternal
endothelial dysfunction, and placental hypoxia as plausible explanations (3, 4).
Preeclampsia is associated with depressed thyroid functions (5). Recent reports showed that
thyroid functions correlate with disease severity and obstetric outcomes in patients suffering from
preeclampsia (6). Evaluation of thyroid function may therefore predict occurrence of preeclampsia
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(7). Moreover, there is accumulating evidence that possibil-
ity of preeclampsia increases if biochemical hypothyroidism
coexists with certain thyroid autoantibodies (8, 9). Studies on
the prevalence of anti-thyroid peroxidase (anti-TPO) and anti-
thyroglobulin (anti-TG) antibodies indicate that thyroid autoim-
munity significantly affects the well-being of the pregnant mother
as well as the fetus independently of the thyroid dysfunction
(10, 11).
In spite of the reports that recommend thyroid hormones [tri-
iodothyronine (T3), thyroxine (T4), and thyroid-stimulating hor-
mone (TSH)] and anti-TPO and anti-TG antibodies as reliable
predictors of preeclampsia and obstetrical outcome, some inves-
tigators have concerns about the efficiency of these parameters
(12–14). Controversy in this regard is probably justifiable by the
inability of some studies to confirm associations betweenmaternal
thyroid function/antibodies and pregnancy/fetal complications
(14–16).
There is an extremely high maternal mortality in Sudan where
preeclampsia/eclampsia is the main cause of obstetric compli-
cations and maternal deaths (17, 18). In Sudan, several aspects
of preeclampsia were investigated (19–23); however, there were
no published data on thyroid function/antibodies in preeclamp-
tic patients. This study aimed to investigate thyroid function
(TSH, free T3, and free T4)/antibodies (anti-TPO and anti-TG)
in patients with preeclampsia.
Patients and Methods
A case–control study was conducted at Wad Medani Hospital,
Central Sudan, during the period of March–July 2013. Cases were
women with preeclampsia, which is defined as the occurrence of
blood pressure140mmHg systolic or90mmHgdiastolic aris-
ing after 20weeks of gestation in a woman who is normotensive
before 20weeks plus presence of 300mgormore of protein in a 24-
h urine sample or2+ in dipstick. Cases were further divided into
mild preeclampsia (MP) and severe preeclampsia (SP) according
to the diastolic blood pressure of <110 or 110mm Hg, respec-
tively. A consecutive control was taken for each case. Controls
were normotensive women (without any blood pressure values
>139/89mm Hg or proteinuria) presented in the antenatal visits.
Women were excluded from the cases and controls if they had
twins or had previous history of thyroid disease, hypertension,
renal disease, diabetes, liver disease, or on medication that might
affect thyroid function.
After signing an informed consent, the sociodemographic,
medical history was taken from each woman (cases and con-
trols) using a questionnaire. Blood pressure was measured using
a sphygmomanometer for both case and control groups. Maternal
weight andheightweremeasured, and bodymass index (BMI)was
calculated and expressed as weight (kg)/height (m)2.
Then, 5ml of venous blood was taken from each respon-
dent, allowed to clot, centrifuged, and stored at  20°C using
immunoassay analyzer (AIA 360, Tosoh, Japan), following the
manufacturer’s instructions, till the assay of the thyroid hor-
mones (TSH, free T3, and free T4). Specific anti-TPO and anti-
TG antibody profiles were analyzed using commercial ELISA
(Euroimmun, Lübeck, Germany) Kits.
A total sample size of 55 women in each arm of the study was
calculated using a formula for the difference in the mean of the
proposed variables (TSH, free T3, and free T4 and anti-TPO and
anti-TG antibodies) which would provide 80% power to detect a
5% difference at α= 0.05 and assumed that 10% of women would
not respond.
Because there were no published data on the normal value for
TSH, free T3, and free T4 among pregnant Sudanese women, 2.5
and 97.5% of the controls were considered as referral values for
these parameters in the third trimester.
Statistical Analysis
Data were entered in a computer using SPSS for Windows (ver-
sion 16.0). Continuous data were compared between the groups
(controls, MP, and SP) using ANOVA and Kruskal–Wallis H
(Mann–Whitney U test between two groups) tests when the
data were normally and not normally distributed, respectively.
Multiple linear regression models were performed where TSH,
Free T3, Free T4, anti-TPO, and anti-TG levels were continuous
dependent variables and age, parity, gestational age, BMI index,
and preeclampsia were the independent predictors of interest. A P
value of<0.05 was considered to be significant.
Ethics
Ethical clearance was obtained from the Research Board at the
Faculty of Medicine, University of Khartoum.
Results
The basic characteristics of the three groups of the controls, MP,
and SP (55 women in each arm) are shown in Table 1 where there
was no significant difference in the age, parity, and BMI. However,
gestational age andhemoglobinwere significantly lower inwomen
with SP (Table 1).
While themedian (interquartile range) of TSHwas significantly
lower, both free T3 and free T4 levels were significantly higher
in women with preeclampsia than in the healthy controls (HCs).
There was no significant difference in the TSH levels in women
with MP and SP (Table 2; Figure 1).
In comparison with MP, women with SP had significantly
higher levels of free T3 and significantly lower levels of free T4
(Table 2; Figure 1). In the control group, the 2.5%was 0.77 IU/ml,
0.51 pg/ml, and 0.65 ng/dl and 97.5% was 5.14 IU/ml, 3.00 pg/ml,
and 1.38 ng/dl for TSH, free T3, and free T4, respectively. About 10
TABLE 1 |Comparing the mean (SD)a of the basic characteristics of women
with preeclampsia and controls.
Variable Controls
(n= 55)
Mild
preeclampsia
(n= 55)
Severe
preeclampsia
(n= 55)
P
Age (years) 27.4 (5.1) 28.1 (4.9) 29.1 (4.7) 0.217
Parity 2.2 (1.5) 2.7 (1.6) 2.9 (1.8) 0.065
Gestational age (weeks) 38.4 (2.0) 37.7 (1.3) 36.1 (2.9) <0.001
Body mass index (kg/cm2) 24.3 (1.9) 24.2 (1.9) 24.6 (2.3) 0.568
Hemoglobin (g/dl) 11.2 (1.2) 10.3 (1.8) 10.0 (1.4) <0.001
aANOVA test was used.
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(9.0%), 0 (0%), and 1 (0.9%) of the 110 preeclamptic women had
low levels of TSH, free T3, and free T4, respectively. On the other
hand, 2 (1.8%), 4 (3.6%), and 5 (4.5%) of the 110 preeclamptic
women had high TSH, free T3, and free T4, respectively.
TABLE 2 | The median (interquartile) of thyroid function and antibodies in
womenwithmild preeclampsia (MP), severe preeclampsia (SP), and healthy
controls (HCs).
Variable Healthy
controls
(n= 55)
Mild
preeclampsia
(n= 55)
Severe
preeclampsia
(n= 55)
P
TSH
(mIU/ml)
2.3 (1.9–2.6) 1.3 (0.9–2.1) 1.5 (1.0–1.9) HC vs. MP, P<0.001
HC vs. SP, P<0.001
MP vs. SP, P= 0.286
Free T3
(pg/ml)
0.7 (0.5–1.3) 2.0 (1.4–2.4) 2.1 (1.9–2.6) HC vs. MP, P<0.001
HC vs. SP, P<0.001
MP vs. SP, P= 0.009
Free T4
(ng/dl)
0.8 (0.7–1.1) 1.1 (1.0–1.2) 0.9 (0.7–1.1) HC vs. MP, P<0.001
HC vs. SP, P=0.235
MP vs. SP, P<0.001
Anti-TPO
(IU/ml)
8.3 (6.4–10.1) 8.7 (6.9–10.7) 10.5 (7.3–13.4) HC vs. MP, P= 0.474
HC vs. SP, P=0.005
MP vs. SP, P= 0.032
Anti-TG
(IU/ml)
11.4 (8.5–13.8) 9.0 (6.8–11.0) 11.1 (8.2–13.2) HC vs. MP, P= 0.002
HC vs. SP, P=0.820
MP vs. SP, P= 0.008
While anti-TPO antibodies were significantly higher, anti-TG
antibodies were significantly lower in women with preeclampsia.
Likewise, anti-TPO antibodies were significantly higher and anti-
TG antibodies were significantly lower in women with SP than in
women with MP (Table 2; Figure 2).
In linear regression, preeclampsia was significantly associ-
ated with TSH ( 0.675 IU/ml, P= 0.009), free T3 (0.977 pg/ml,
P< 0.001), and free T4 (0.186 ng/dl, P< 0.001) levels (Table 3).
Interestingly, there was no association between preeclampsia and
both antibodies levels (Table 4).
There was no association between TSH and free T3, free T4 and
antibodies. Free T3 was significantly associated with free T4 and
with anti-TPO and anti-TG. Free T4 was significantly associated
with anti-TG (Table 3).
Discussion
The main findings of the current study were then compared with
HC women; preeclamptic women had significantly lower levels of
TSH and anti-TG and significantly higher levels of free T3, free
T4, and anti-TPO.
This finding disagrees with previous findings from other stud-
ies (24–26), although the reported deviations of free T3, free T4,
and TSH concentrations from normal physiological levels were
quite variable. A recent study showed lower thyroid hormones
and higher TSH levels in both early and late preeclampsia groups
FIGURE 1 | TSH, free T3, and T4 among women with preeclampsia in Medani Hospital, Sudan.
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FIGURE 2 | Anti-TPO and anti-TG among women with preeclampsia in Medani Hospital, Sudan.
TABLE 3 | Linear regression analysis of factors associated with TSH, Free T3, and Free T4 levels.
Variable TSH Free T3 Free T4
R= 0.379 and R2= 0.084 R= 0.683 and R2= 0.429 R= 0.454 and R2= 0.158
Coefficient SE P Coefficient SE P Coefficient SE P
Age 0:030 0.022 0.169 0:006 0.013 0:664 0:003 0.005 0:593
Parity  0:032 0.064 0.620  0:023 0.038 0:551  0:014 0.014 0:313
Gestational age  0:018 0.041 0.663  0:011 0.022 0:605 0:016 0.008 0:061
Body mass index  0:026 0.043 0.544 0:031 0.025 0:226  0:006 0.009 0:547
Hemoglobin 0:001 0.057 0.980  0:037 0.034 0:268 0:006 0.013 0:639
Preeclampsia  0:675 0.253 0.009 0:977 0.126 <0:001 0:186 0.045 <0:001
Free T3  0:183 0.139 0.192 – – – 0:513 0.215 0:018
Free T4 0:415 0.373 0.268 0:513 0.215 0:018 – – –
Anti-TPO 0:026 0.016 0.101 0:017 0.009 0:078 0:004 0.004 0:236
Anti-TG  0:003 0.016 0.861 0:012 0.009 0:172  0:011 0.003 0:001
compared to the control subjects; however, all hormone con-
centrations were comparable in both early and later preeclamp-
sia (27). Zhou et al. observed that the decline in thyroid func-
tion is proportional to the deterioration in renal function that
complicates cases of SP (8). A case–control study conducted in
the antenatal clinic of a public hospital in Delhi showed sig-
nificantly higher TSH levels in preeclampsia group compared
to controls; however, mean values of thyroid hormones were
in the normal range (25). In another study, maternal serum
TSH was proven to be an acceptable predictor of premature
labor in patients with preeclampsia (26). Alternatively, stud-
ies that failed to demonstrate hypothyroidism in patients with
preeclampsia are not uncommon (11, 12, 14). Based on the
results of Qublan et al., there were no significant differences in
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TABLE 4 | Linear regression analysis of factors associated with anti-TPO
and anti-TG levels.
Variable Anti-TPO Anti-TG
R= 0.470 and R2= 0.441 R= 0.179 and R2= 0.151
Coefficient SE P Coefficient SE P
Age  0:156 0.108 0:151 0:100 0.127 0.433
Parity 0:746 0.317 0:020  0:383 0.373 0.305
Gestational
age
0:116 0.184 0:530  0:288 0.217 0.185
Body mass
index
0:118 0.210 0:577 0:070 0.248 0.778
Hemoglobin 0:037 0.289 0:898 0:168 0.341 0.623
Preeclampsia  1:832 0.996 0:068 1:003 1.174 0.394
Anti-TG 0:397 0.068 <0:001 – – –
the levels of FT4, FT3, and TSH between the patients with SP
and healthy normotensive controls regardless of the gestational
age (15). Nine years later, Khadem and his group were able to
reproduceQublan et al.’s findings in Iranian pregnantwomen (12).
Yet, at least one study reported a significantly higher T3 level in
patients with SP compared to healthy pregnant women (13). This
disagreement is possibly due to examining patients with different
ethnicity, BMI, gestational ages, and parities (28–31).
In the current study, while anti-TPO antibodies were signif-
icantly higher, anti-TG antibodies were significantly lower in
women with preeclampsia. Likewise, anti-TPO antibodies were
significantly higher and anti-TG antibodies were significantly
lower in women with SP than in women with MP. These findings
agree with several previous reports (9, 32), but not others (14, 16).
The study byMecacci et al. reported positive anti-TPO in 33.3% of
patients with preeclampsia, which was a significantly higher ratio
when compared to the HC pregnant women (14.5%) (32). Con-
trary to this, a study evaluating the association between mater-
nal thyroid dysfunction/antibodies and pregnancy complications
failed to prove predictive values of these parameters for neither
preeclampsia nor maternal mortality (16). A separate study adds
more to the disputes by confirming higher levels of anti-TPO
antibodies in HC subjects compared to patients with gestational
hypertension, preeclampsia, or eclampsia (14).
Incongruent with previous reports, the present results fail to
demonstrate influences of parity and gestational age on maternal
thyroid function/antibodies (28, 33–35). A cross-sectional study
conducted in 50 non-pregnant women as a control group, 50
primiparae and 50 multiparae women showed increased serum
levels of T4 and T3 in both groups, while serum level of TSH
decreased significantly in the two groups (35).Higher levels of thy-
roid hormones in multiparae women in iodine deficient regions
may explain their higher risk to develop multinodular goiter (35).
Based on the data used to establish pregnancy-specific thyroid
function reference intervals of a southern Chinese population,
TSH is likely to increase while thyroid hormones decrease in
advanced gestational ages (28). The same findings were repro-
duced byKhalid and his groupwhen they studied thyroid function
in pregnant women attending a large, tertiary referral maternity
hospital in Ireland (33). In addition, the study by Khalid et al.
documented significant positive correlation between anti-TPO
antibodies, gestational age and TSH, but not T4.
The limitations of the current study were that iodine was not
investigated in these women and the thyroid function/antibodies
were investigated in the third trimester after the diagnosis of the
preeclampsia. There were no referral values for thyroid functions
in pregnant Sudanese women. Yet, Elnagar et al. in a longitudi-
nal small sample size study (28 women) reported that the mean
FT4 values in Sudanese showed no significant changes during
pregnancy, and 23, 40, and 14% of whom had FT4 values below
the reference range in the first, second, and third trimesters,
respectively, and none of them showed FT4 values above the
reference range (36). The later study reported that these pregnant
Sudanese women had iodine deficiency. Previous reports showed
that the mean FT4 levels of the goitrous pregnant Sudanese
women were significantly lower than that of the non-pregnant
control group (37). A longitudinal study investigating the thy-
roid function/antibodies and iodine correlated with pregnancy
outcome is needed.
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